“More than any of the other doctrines in patent law, the novelty requirement epitomizes the patent system’s failure to adequately promote pharmaceutical innovation by ignoring the development and commercialization costs of inventions.”
Ben Roin
Academic Fellow 2006-08
Assistant Professor 2008